An Agilent-owned Canadian CDMO with officially disclosed pDNA, mRNA, and LNP formulation capabilities.
CanadaFull profile →
mRNA / LNP · Companies
Matching companies load automatically. Browse 24 companies per page; expand filters to narrow the results.
Search & refine Filters update automatically
Disease tags identify mentions in recorded facts or pipeline text, not approved indications or a complete pipeline. Platform service providers may have no disease-specific tag.
51 matching companiesShowing 49–51 / 51
Offers mRNA drug substance and drug product services, including process development, analysis, and product characterization. Each site's project scope requires confirmation.
South KoreaFull profile →
Offers mRNA process development and cGMP manufacturing based on microbial, DNA, and RNA production and analytical capabilities. Capabilities are not necessarily equivalent across all AGC sites.
Japan / United States / GermanyFull profile →
Coverage expands from sourced records; this database does not claim all biopharma companies.